Cargando…
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report
Germ cell tumors (GCTs) comprise 95% of malignant tumors arising in the testes. The present study reports a patient diagnosed with non-seminomatous testicular cancer, stage IB, with a good risk prediction according to the International Germ Cell Cancer Collaborative Group classification. The patient...
Autores principales: | BLANCAS, ISABEL, CÁRDENAS, NURIA, DELGADO, MAYTE, JURADO, JOSE MIGUEL, LEGEREN, MARTA, VILLAESCUSA, ANA, GALVEZ, FERNANDO, YELAMOS, MARISOL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186558/ https://www.ncbi.nlm.nih.gov/pubmed/25289098 http://dx.doi.org/10.3892/ol.2014.2519 |
Ejemplares similares
-
Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report
por: JURADO, JOSÉ MIGUEL, et al.
Publicado: (2013) -
Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor
por: Xavier, Rosana, et al.
Publicado: (2020) -
Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020) -
Compliance with follow-up of patients treated for non-seminomatous testicular cancer.
por: Young, B. J., et al.
Publicado: (1991) -
A case of prostatic metastasis from non‐seminomatous testicular cancer
por: Noda, Taisho, et al.
Publicado: (2023)